BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
Completed · Not applicable
Conditions studied: Gynecologic Cancer, Gastrointestinal Cancer
In brief
This research study is evaluating a new intervention, BOLSTER, which was designed to provide more support for patients with gynecologic and gastrointestinal cancers and their caregivers after a hospitalization.
Key facts
- Study ID
- NCT03367247
- Run by
- Dana-Farber Cancer Institute
- People needed
- 121
- Starts
- 2018-04-24
- Expected to finish
- 2023-07-27
- Last updated by the study team
- 2026-03-10
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.